Charles A. O' Neill

Person

Vineburg, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 11,229,687
- Issue date Jan 25, 2022
- Biomarin Pharmaceutical Inc.
- Thomas Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of C-type natriuretic peptide variants to treat osteoarthritis
- Patent number 11,202,819
- Issue date Dec 21, 2021
- Biomarin Pharmaceutical Inc.
- Charles A. O'Neill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 10,758,598
- Issue date Sep 1, 2020
- Biomarin Pharmaceutical Inc.
- Thomas Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 10,279,015
- Issue date May 7, 2019
- Biomarin Pharmaceutical Inc.
- Thomas W. Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF TREATING DUCHENNE MUSCULAR DYSTROPHY
- Publication number 20230416741
- Publication date Dec 28, 2023
- BioMarin Pharmaceutical Inc.
- Charles A. O'Neill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF EYE DISORDERS WITH URIDINE PHOSPHATE DERIVATIVES
- Publication number 20230165885
- Publication date Jun 1, 2023
- GLIAGUARD, INC.
- Charles O'Neill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS
- Publication number 20220160836
- Publication date May 26, 2022
- BioMarin Pharmaceutical Inc.
- Charles A. O'Neill
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TPP-1 Formulations and Methods for Treating CLN2 Disease
- Publication number 20200353059
- Publication date Nov 12, 2020
- BioMarin Pharmaceutical Inc.
- Thomas Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS
- Publication number 20190247467
- Publication date Aug 15, 2019
- BioMarin Pharmaceutical Inc.
- CHARLES A. O'NEILL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TPP-1 Formulations and Methods for Treating CLN2 Disease
- Publication number 20190216905
- Publication date Jul 18, 2019
- BioMarin Pharmaceutical Inc.
- Thomas Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TPP-1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE
- Publication number 20160324942
- Publication date Nov 10, 2016
- BioMarin Pharmaceutical Inc.
- Thomas W. Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Charles A. O' Neill

Person

Patents Grantslast 30 patents

TPP-1 formulations and methods for treating CLN2 disease

Use of C-type natriuretic peptide variants to treat osteoarthritis

TPP-1 formulations and methods for treating CLN2 disease

TPP-1 formulations and methods for treating CLN2 disease

Patents Applicationslast 30 patents

METHOD OF TREATING DUCHENNE MUSCULAR DYSTROPHY

TREATMENT OF EYE DISORDERS WITH URIDINE PHOSPHATE DERIVATIVES

USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS

TPP-1 Formulations and Methods for Treating CLN2 Disease

USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS

TPP-1 Formulations and Methods for Treating CLN2 Disease

TPP-1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE